Literature DB >> 20202464

An update on the role of interim restaging FDG-PET in patients with diffuse large B-cell lymphoma and Hodgkin lymphoma.

Craig H Moskowitz1, Andrew Zelenetz, Heiko Schoder.   

Abstract

A significant amount of literature is available on treatment monitoring and response assessment in lymphoma using FDG-PET, yet confusion exists concerning the potential and limitations of FDG-PET for determining the presence of residual disease during chemotherapy (interim FDG-PET). This article reviews the role of interim FDG-PET in 3 important scenarios: untreated diffuse large B-cell lymphoma, untreated Hodgkin lymphoma, and relapsed or refractory aggressive lymphoma in transplant-eligible patients, and provides recommendations on the use of this imaging modality in these settings.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20202464     DOI： 10.6004/jnccn.2010.0023

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


  7 in total

Review 1.  Hodgkin's lymphoma therapy: past, present, and future.

Authors:  Bharti Rathore; Marshall E Kadin
Journal:  Expert Opin Pharmacother       Date:  2010-12       Impact factor: 3.889

2.  The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma.

Authors:  Deepa Bhojwani; Mary B McCarville; John K Choi; Jennifer Sawyer; Monika L Metzger; Hiroto Inaba; Andrew M Davidoff; Robert Gold; Barry L Shulkin; John T Sandlund
Journal:  Br J Haematol       Date:  2014-11-10       Impact factor: 6.998

3.  Prognostic Role of Interim 18-Fluorodeoxyglucose-PET in Diffuse Large B Cell Lymphoma: Experience from a Tertiary Care Centre in North India.

Authors:  Sujeet Kumar; Anshul Gupta; Manish Ora; Khaliqur Rahman; Reena Choudhary; Soniya Nityanand
Journal:  Indian J Hematol Blood Transfus       Date:  2021-05-04       Impact factor: 0.900

4.  FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy.

Authors:  F L Day; E Link; S Ngan; T Leong; K Moodie; C Lynch; M Michael; E de Winton; A Hogg; R J Hicks; A Heriot
Journal:  Br J Cancer       Date:  2011-07-26       Impact factor: 7.640

Review 5.  Image-guided radiation therapy in lymphoma management.

Authors:  Tony Eng; Chul S Ha
Journal:  Radiat Oncol J       Date:  2015-09-30

6.  Interim PET-CT may predict PFS and OS in T-ALL/LBL adult patients.

Authors:  Liang Wang; Jing-Hua Wang; Xi-Wen Bi; Xiao-Qin Chen; Yue Lu; Zhong-Jun Xia
Journal:  Oncotarget       Date:  2017-07-26

7.  Noninvasive phosphorus magnetic resonance spectroscopic imaging predicts outcome to first-line chemotherapy in newly diagnosed patients with diffuse large B-cell lymphoma.

Authors:  Fernando Arias-Mendoza; Geoffrey S Payne; Kristen Zakian; Marion Stubbs; Owen A O'Connor; Hamed Mojahed; Mitchell R Smith; Adam J Schwarz; Amita Shukla-Dave; Franklyn Howe; Harish Poptani; Seung-Cheol Lee; Ruth Pettengel; Steven J Schuster; David Cunningham; Arend Heerschap; Jerry D Glickson; John R Griffiths; Jason A Koutcher; Martin O Leach; Truman R Brown
Journal:  Acad Radiol       Date:  2013-09       Impact factor: 3.173
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.